We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Landmark First Research Test Kit for Systemic Sclerosis Launched

By LabMedica International staff writers
Posted on 24 Aug 2014
A novel combination of biomarkers has been developed into a test kit to facilitate diagnostics research of systemic sclerosis specifically and complex autoimmune diseases in general.

Protagen AG (Dortmund, Germany), dedicated to development of novel diagnostic and companion diagnostic tests to provide better and earlier diagnosis of severe autoimmune diseases, has launched its first ELISA, currently research-use-only, test kit – the ADx SSc Multilisa – for Systemic Sclerosis (SSc; also termed scleroderma), a complex, multi-organ rheumatic disease in which autoimmune dysregulation leads to a complex pattern of organ-specific complications associated with high mortality and morbidity. More...
Protagen developed the new assay to synergistically combine 2 proprietary, novel disease markers with 2 standard diagnostic markers to support medical research in autoimmune diseases.

Stefan Müllner, CEO of Protagen AG, said, “Based on our long track record in the discovery and validation of autoantigen biomarkers using the proprietary SeroTag technology, our development pipeline is built on a strong patent portfolio and designed to support clinical research, targeted therapy, and the continuous delivery of novel diagnostic products.” The 3 most frequently observed autoantibodies are only present in about 60%-70% of SSc patients: anti-topoisomerase I (anti-Scl70), anti-centromere (ACA), and anti-RNA polymerase III (ARA). Protagen has focused on the identification of a new class of biomarkers for SSC to augment current diagnostic tools. Extensive research via the company´s SeroTag platform revealed 2 novel SSc-associated antigens: KDM6B and BICD2. The ADx SSc Multilisa kit enables simultaneous qualitative in vitro detection of antibodies against domains of Scl-70 (topoisomerase I),CENP-B, KDM6B, and BICD2, within human serum or plasma.

SSc is one of a number of complex autoimmune diseases that Protagen is working to address with tools to help clinical researchers identify markers for improved diagnostic and this new introduction represents a key milestone in the company’s pipeline. Mr. Müllner added, “This underscores our strategy to provide new, improved solutions and product options in autoimmune indications on a continuous basis, enable better therapeutic decision making, and improve the diagnostic process for clinicians and, importantly, patients.”

ADx SSc Multilisa is currently intended for use as a scientific research-use-only (RUO) tool, and is in further clinical testing to build a diagnostic claim for early disease detection or stratification from August 2014.

Related Links:

Protagen



New
Gold Member
Automatic Hematology Analyzer
DH-800 Series
Portable Electronic Pipette
Mini 96
Gel Cards
DG Gel Cards
Sperm Quality Analyis Kit
QwikCheck Beads Precision and Linearity Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New evidence shows viscoelastic testing can improve assessment of blood clotting during postpartum hemorrhage (Photo courtesy of 123RF)

Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage

Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more

Industry

view channel
Image: The collaboration aims to improve access to Hb variant testing with the Gazelle POC diagnostic platform (Photo courtesy of Hemex Health)

Terumo BCT and Hemex Health Collaborate to Improve Access to Testing for Hemoglobin Disorders

Millions of people worldwide living with sickle cell disease and other hemoglobin disorders experience delayed diagnosis and limited access to effective care, particularly in regions where testing is scarce.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.